Kaymaz-Tahra, S. Et Al. 2024. Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms. ARTHRITIS & RHEUMATOLOGY , 5132-5134.

Kaymaz-Tahra, S., Tsechelidis, O. B., Ince, B., ÖZDEMİR IŞIK, Ö., Kutu, M. E., Karakas, O., ... DEMİRCİ YILDIRIM, T.(2024). Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms. ARTHRITIS & RHEUMATOLOGY , 5132-5134.

Kaymaz-Tahra, Sema Et Al. "Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms," ARTHRITIS & RHEUMATOLOGY , 5132-5134, 2024

Kaymaz-Tahra, Sema Et Al. "Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms." ARTHRITIS & RHEUMATOLOGY , pp.5132-5134, 2024

Kaymaz-Tahra, S. Et Al. (2024) . "Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms." ARTHRITIS & RHEUMATOLOGY , pp.5132-5134.

@article{article, author={Sema Kaymaz-Tahra Et Al. }, title={Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2024, pages={5132-5134} }